| Product Code: ETC13357067 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America AI Precision Medicine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America AI Precision Medicine Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America AI Precision Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 North America AI Precision Medicine Market - Industry Life Cycle |
3.4 North America AI Precision Medicine Market - Porter's Five Forces |
3.5 North America AI Precision Medicine Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America AI Precision Medicine Market Revenues & Volume Share, By Market Type, 2021 & 2031F |
3.7 North America AI Precision Medicine Market Revenues & Volume Share, By Solution Type, 2021 & 2031F |
3.8 North America AI Precision Medicine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 North America AI Precision Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 North America AI Precision Medicine Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America AI Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America AI Precision Medicine Market Trends |
6 North America AI Precision Medicine Market, 2021 - 2031 |
6.1 North America AI Precision Medicine Market, Revenues & Volume, By Market Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America AI Precision Medicine Market, Revenues & Volume, By Diagnostics, 2021 - 2031 |
6.1.3 North America AI Precision Medicine Market, Revenues & Volume, By Personalized Treatment, 2021 - 2031 |
6.1.4 North America AI Precision Medicine Market, Revenues & Volume, By Drug Discovery, 2021 - 2031 |
6.1.5 North America AI Precision Medicine Market, Revenues & Volume, By Disease Risk Prediction, 2020 - 2028 |
6.2 North America AI Precision Medicine Market, Revenues & Volume, By Solution Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America AI Precision Medicine Market, Revenues & Volume, By AI-Assisted Imaging, 2021 - 2031 |
6.2.3 North America AI Precision Medicine Market, Revenues & Volume, By Genetic AI, 2021 - 2031 |
6.2.4 North America AI Precision Medicine Market, Revenues & Volume, By AI-Driven Research, 2021 - 2031 |
6.2.5 North America AI Precision Medicine Market, Revenues & Volume, By AI Biomarkers, 2021 - 2031 |
6.3 North America AI Precision Medicine Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America AI Precision Medicine Market, Revenues & Volume, By Deep Learning, 2021 - 2031 |
6.3.3 North America AI Precision Medicine Market, Revenues & Volume, By Predictive Analytics, 2021 - 2031 |
6.3.4 North America AI Precision Medicine Market, Revenues & Volume, By Machine Learning, 2021 - 2031 |
6.3.5 North America AI Precision Medicine Market, Revenues & Volume, By NLP, 2021 - 2031 |
6.4 North America AI Precision Medicine Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.2 North America AI Precision Medicine Market, Revenues & Volume, By Cancer Detection, 2021 - 2031 |
6.4.3 North America AI Precision Medicine Market, Revenues & Volume, By Chronic Disease Management, 2021 - 2031 |
6.4.4 North America AI Precision Medicine Market, Revenues & Volume, By Drug Development, 2020 - 2028 |
6.4.5 North America AI Precision Medicine Market, Revenues & Volume, By Preventive Healthcare, 2020 - 2028 |
6.5 North America AI Precision Medicine Market, Revenues & Volume, By End User, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 North America AI Precision Medicine Market, Revenues & Volume, By Hospitals, 2020 - 2028 |
6.5.3 North America AI Precision Medicine Market, Revenues & Volume, By Clinics, 2020 - 2028 |
6.5.4 North America AI Precision Medicine Market, Revenues & Volume, By Pharma Companies, 2020 - 2028 |
6.5.5 North America AI Precision Medicine Market, Revenues & Volume, By Individuals, 2020 - 2028 |
7 North America AI Precision Medicine Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America AI Precision Medicine Market, Revenues & Volume, By Market Type, 2021 - 2031 |
7.2.1 United States (US) AI Precision Medicine Market, Revenues & Volume, By Market Type, 2021 - 2031 |
7.2.2 Canada AI Precision Medicine Market, Revenues & Volume, By Market Type, 2021 - 2031 |
7.2.3 Rest of North America AI Precision Medicine Market, Revenues & Volume, By Market Type, 2021 - 2031 |
7.3 North America AI Precision Medicine Market Revenues & Volume Share, By Solution Type, 2021 & 2031F |
7.3.1 United States (US) AI Precision Medicine Market, Revenues & Volume, By Solution Type, 2021 - 2031 |
7.3.2 Canada AI Precision Medicine Market, Revenues & Volume, By Solution Type, 2021 - 2031 |
7.3.3 Rest of North America AI Precision Medicine Market, Revenues & Volume, By Solution Type, 2021 - 2031 |
7.4 North America AI Precision Medicine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.1 United States (US) AI Precision Medicine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.2 Canada AI Precision Medicine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.3 Rest of North America AI Precision Medicine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5 North America AI Precision Medicine Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.1 United States (US) AI Precision Medicine Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.2 Canada AI Precision Medicine Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.3 Rest of North America AI Precision Medicine Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6 North America AI Precision Medicine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.1 United States (US) AI Precision Medicine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.2 Canada AI Precision Medicine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.3 Rest of North America AI Precision Medicine Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America AI Precision Medicine Market Key Performance Indicators |
9 North America AI Precision Medicine Market - Export/Import By Countries Assessment |
10 North America AI Precision Medicine Market - Opportunity Assessment |
10.1 North America AI Precision Medicine Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America AI Precision Medicine Market Opportunity Assessment, By Market Type, 2021 & 2031F |
10.3 North America AI Precision Medicine Market Opportunity Assessment, By Solution Type, 2021 & 2031F |
10.4 North America AI Precision Medicine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.5 North America AI Precision Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
10.6 North America AI Precision Medicine Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America AI Precision Medicine Market - Competitive Landscape |
11.1 North America AI Precision Medicine Market Revenue Share, By Companies, 2022 |
11.2 North America AI Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here